Recent technological advancements in compression therapy are significantly driving market growth by enhancing the effectiveness, convenience, and appeal of compression therapy products.
Advances in materials and design allow for more precise and customizable compression levels, ensuring that therapy is tailored to individual patient needs. This improves therapeutic outcomes and patient satisfaction.
For instance, Medi’s CircAid JuxtaFit offers adjustable compression through a series of inelastic bands, allowing users to achieve the desired compression level without needing assistance. It includes a built-in pressure system guide card to ensure accurate application.
Additionally, the development of lightweight, breathable antimicrobial coatings, and moisture-wicking materials increases the comfort of compression garments, making them more suitable for long-term wear. For instance, Juzo SoftCompress incorporates soft, breathable materials that are gentle on the skin, improving comfort and compliance for users requiring lymphedema management.
Moreover, the integration of wearable technology in compression garments offers convenience and continuous monitoring, making it easier for users to incorporate compression therapy into their daily routines. For instance, WearEase Compression Garments that feature seamless and ergonomic designs, provide targeted compression with enhanced comfort, particularly beneficial for post-surgical recovery. These advancements attract more users, encourage higher compliance and long-term use, further fueling the expansion of the market.
Authors:
Mariam Faizullabhoy , Gauri Wani
Frequently Asked Questions (FAQ) :
The global compression therapy industry was valued at around USD 3.4 billion in 2023 and is expected grow at a CAGR of 5.5% during 2024-2032, attributed to technological advancements, and the increasing prevalence of chronic venous disorders and lymphedema.
The compression garments segment of compression therapy industry was worth USD 1.7 billion in 2023, as they are used to treat a variety of conditions, including varicose veins, lymphedema, chronic venous occlusions treatment, deep vein thrombosis (DVT), and post-surgical recovery.
North America compression therapy industry was valued at USD 1.1 billion in 2023 and is predicted to witness substantial growth through 2032, on account of increased prevalence of conditions such as venous disorders, diabetes, obesity, and cardiovascular diseases.
ArjoHuntleigh, BIO Compression Systems, Inc., Cardinal Health, Inc., ConvaTec Inc., DJO Global Inc., Essity AB, and Julius Zorn GmbH among others.